PAVmed Inc
NASDAQ:PAVM 4:00:00 PM EDT
| Market Cap (Intraday) | 16.97M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.93 |
| 50-Day MA | $2.19 |
| 200-Day MA | $3.28 |
PAVmed Inc Stock, NASDAQ:PAVM
360 Madison Avenue, 25th floor, New York, New York 10017
United States of America
Phone: +1.212.949.4319
Number of Employees: 107
Description
PAVmed, Inc. is a commercial-stage technology medical device company, which engages in the commercialization of medical technologies. It operates through the following divisions: Medical Devices, Diagnostics, Digital Health, and Emerging Innovations. The company's products include cell collection devices, esophageal DNA tests, carpal tunnel release, implantable intraosseous vascular access devices, and antimicrobial resorbable ear tubes. PAVmed was founded on June 26, 2014 and is headquartered in New York, NY.